Cocktail fans are likely familiar with ANGOSTURA aromatic bitters® and the enhancing effect bitters can have on alcoholic beverages, but what they might not know is that the story of THE HOUSE OF ANGOSTURA® and ANGOSTURA® aromatic bitters spans beyond craft cocktails. THE HOUSE OF ANGOSTURA wants consumers to take inspiration from the brand’s rich history to make ANGOSTURA aromatic bitters an everyday staple. From culinary uses to signature cocktails, such as the Queen’s Park Swizzle, THE HOUSE OF ANGOSTURA is making a push to ensure ANGOSTURA aromatic bitters secure a permanent spot not only in consumers’ bar carts but also in their pantries.
“Visitors will find ANGOSTURA aromatic bitters alongside salt and pepper in any establishment on the islands of Trinidad and Tobago. We sprinkle a few drops on everything from pizza to soup, ensuring a kick of bold flavor in everything we consume,” said THE HOUSE OF ANGOSTURA CEO Genevieve Jodhan. “I am delighted that people worldwide are already integrating ANGOSTURA bitters into their favorite cocktail recipes, but my hope is that consumers will continue to discover that bitters’ versatile flavor can enhance everything from easy week-night meals to extravagant desserts.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8163051-the-house-of-angostura-bitters-culinary-creations-cocktails/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
littleBits, the award-winning company that empowers kids to be inventors, today announced the launch of its Droid Inventor Kit, which enables kids to create their own Droid. An integral part of the global launch of Disney and Lucasfilm's Force Friday II, the Droid Inventor Kit brings Droids to life, inspiring imagination and invention for kids around the world. Kids can easily create and power up their own mechanical companion using littleBits electronic Bits--along with the free Droid Inventor app--to send their creation on more than 17 special Star Wars missions, complete with authentic Droid sounds from the Star Wars films. As they unlock new capabilities and level up their Droid Inventor skills, kids can also learn how to create their own custom R2 Units and experiences, combining play with real hands-on learning.
“Today we are continuing a global inventor movement that empowers young people to participate in a story that inspires them to be creators, not just consumers of technology,” said Ayah Bdeir, founder & CEO of littleBits. “We’ve created a gender-inclusive product that celebrates kids’ own self-expression and ingenuity, while showcasing the same characteristics of imagination, grit and invention that are embodied in the Star Wars franchise.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8170651-littlebits-droid-inventor-kit-star-wars-kids-toys-stem/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
